← TrialMatch
HomeTrials

Role of "Asthma School" in Disease Management

According to the definition provided by the GINA guidelines, asthma is characterized by a variable and reversible limitation of expiratory airflow and by the following symptoms: wheezing, dyspnoea, thoracic constriction and/or cough. The type and the severity of airflow limitation can vary over time (1) depending on ex

Condition(s)Asthma
StatusRecruiting
PhaseNA
Study typeInterventional
SummaryAccording to the definition provided by the GINA guidelines, asthma is characterized by a variable and reversible limitation of expiratory airflow and by the following symptoms: wheezing, dyspnoea, thoracic constriction and/or cough. The type and the severity of airflow limitation can vary over time (1) depending on external agents, such as physical exercise, polluting agents, climate changes and viral infections. The therapy is mainly based on the use of inhaled corticosteroids and bronchodilators. Patients affected by severe asthma (\~ 10% of total prevalence of asthma and at high risk of exacerbations and/or hospitalization) may not control their symptoms, even if exposed to maximal doses of inhalation therapy.The behavioural sciences can potentially help to find the psychological facto
Who can participateInclusion Criteria: * Asthma diagnosis according to GINA / ATS guidelines. * Age ≥18 years Exclusion Criteria: •cognitive impairment
Ages18 Years to 85 Years
SexAll
Lead sponsorIstituti Clinici Scientifici Maugeri SpA
LocationsTradate, Lombardy, Italy
Start date2019-04-01
NCT IDNCT04442646
Official listinghttps://clinicaltrials.gov/study/NCT04442646

🔍 Search all trials →